Showing results (241-250 of 251) with videos related to

Sort By:
Pageof 26
Biorxiv : the Preprint Server for Biology|December 9, 2024
An estrogen receptor signaling transcriptional program linked to immune evasion in human hormone receptor-positive breast cancerKenichi Shimada, Daniel E Michaud, Yvonne Xiaoyong Cui, et al.
Blood Advances|February 11, 2021
A pragmatic multi-institutional approach to understanding transplant-associated thrombotic microangiopathy after stem cell transplantChristopher E Dandoy, Seth Rotz, Priscila Badia Alonso, et al.
Pediatric Blood & Cancer|November 24, 2025
Central Venous Catheter Removal After Hematopoietic Stem Cell Transplant: A Review and PerspectiveEleanor Cook, Seth J Rotz, Jeffery J Auletta, et al.
Pediatric Blood & Cancer|September 6, 2019
Outcomes after bloodstream infection in hospitalized pediatric hematology/oncology and stem cell transplant patientsChristopher E Dandoy, Tammy Kelley, Aditya H Gaur, et al.
The Journal of Experimental Medicine|August 26, 2022
CD8 coreceptor engagement of MR1 enhances antigen responsiveness by human MAIT and other MR1-reactive T cellsMichael N T Souter, Wael Awad, Shihan Li, et al.
International Journal of Cardiology|February 17, 2022
Long-term outcomes of early-onset myocardial infarction with non-obstructive coronary artery disease (MINOCA)Giulia Magnani, Serena Bricoli, Maddalena Ardissino, et al.
Transplantation and Cellular Therapy|January 1, 2025
Engraft: A Collaborative Learning Health Network for Enhanced Transplant and Cellular Therapy OutcomesChristopher E Dandoy, Jeffery J Auletta, Priscila Badia, et al.
Angiogenesis|September 1, 2018
Understanding the evolving phenotype of vascular complications in telomere biology disordersCecilia Higgs, Yanick J Crow, Denise M Adams, et al.
American Journal of Human Genetics|October 31, 2025
BRCA1-, BRCA2-, and PALB2-related Fanconi anemia: Scope to expand disease phenotypic features and predict breast cancer risk in heterozygotesSharon E Johnatty, Emma Tudini, Michael T Parsons, et al.
Nature Communications|December 3, 2024
Compassionate access to virus-specific T cells for adoptive immunotherapy over 15 yearsMichelle A Neller, George R Ambalathingal, Nada Hamad, et al.
Pageof 26